A determination of the relative affinity of vancomycin and ristocetin for isolated cell walls and for a peptidoglycan precursor was made. These antibiotics had previously been shown to adsorb to cell walls and to complex with peptides containing a D-alanyl-D-alanine C-terminus. By using 14C-uridine diphosphate (UDP)-Nacetylmuramyl pentapeptide, it was shown that the complex which is formed between this peptidoglycan precursor and either vancomycin or ristocetin does not preclude adsorption of the antibiotics to cell walls of Micrococcus lysodeikticus. Complex formation between ristocetin and UDP-N-acetylmuramyl pentapeptide was assured by differential absorption spectra. However, when the complex was mixed with cell walls, the antibiotic was sedimented with the walls, and the radioactivity remained in the supernatant solution. This indication that ristocetin and vancomycin have a greater affinity for walls than for UDP-N-acetylmuramyl pentapeptide and that the complex per se does not bind to cell walls suggests that adsorption of these antibiotics to cell walls is probably responsible for the inhibition of peptidoglycan synthesis. This proposal is strengthened by the observation that complexed antibiotic is no less inhibitory for growth of Bacillus subtilis than free vancomycin or ristocetin.
A determination of the relative affinity of vancomycin and ristocetin for isolated cell walls and for a peptidoglycan precursor was made. These antibiotics had previously been shown to adsorb to cell walls and to complex with peptides containing a D-alanyl-D-alanine C-terminus. By using 14C-uridine diphosphate (UDP)-Nacetylmuramyl pentapeptide, it was shown that the complex which is formed between this peptidoglycan precursor and either vancomycin or ristocetin does not preclude adsorption of the antibiotics to cell walls of Micrococcus lysodeikticus. Complex formation between ristocetin and UDP-N-acetylmuramyl pentapeptide was assured by differential absorption spectra. However, when the complex was mixed with cell walls, the antibiotic was sedimented with the walls, and the radioactivity remained in the supernatant solution. This indication that ristocetin and vancomycin have a greater affinity for walls than for UDP-N-acetylmuramyl pentapeptide and that the complex per se does not bind to cell walls suggests that adsorption of these antibiotics to cell walls is probably responsible for the inhibition of peptidoglycan synthesis. This proposal is strengthened by the observation that complexed antibiotic is no less inhibitory for growth of Bacillus subtilis than free vancomycin or ristocetin.
Vancomycin and ristocetin are closely related antibiotic inhibitors of peptidoglycan synthesis by gram-positive organisms (2, 7, 15) . There have recently been two similar mechanisms advanced to account for the inhibition of cell wall synthesis by these antibiotics. The first, the mechanism of Best and Durham (3) , was based on the demonstrated adsorption of vancomycin and ristocetin to isolated cell walls of Bacillus subtilis. They presented evidence to suggest that ionic linkages were involved in the adsorption and suggested that a physical or steric interference with peptidoglycan polymerization resulted from those antibiotic molecules adsorbed proximal to the site(s) of addition of the disaccharide pentapeptide precursor to the existing polymer (3) .
An alternative mechanism of action of these antibiotics was recently proposed by Perkins (10) . By using differential ultraviolet absorption spectra, Perkins demonstrated that both vancomycin and ristocetin formed a stable complex of unknown nature with not only the uridine diphosphate (UDP)-N-acetylmuramyl pentapeptide precursor for peptidoglycan synthesis, but also with several peptides. In each case, complex formation was shown to require an acyl-D-alanyl-D-alanine C-terminal sequence. Since the required amino acid sequence has only been found in association with the peptidoglycan precursor, Perkins considered the specificity exhibited by vancomycin and ristocetin toward this peptide to be improbable if it was not related to the inhibition of cell wall synthesis. Since two logical mechanisms of inhibition of peptidoglycan synthesis by vancomycin and ristocetin exist, this study was undertaken to determine whether the antibiotic complex between insoluble cell wall or soluble peptidoglycan precursor is more relevant to the biological activity.
MATERIALS AND METHODS
Microorganisms. Micrococcus After 12 to 14 hr growth, the micrococci were harvested by continuous-flow centrifugation at 25,000 X g. The cell pellets were washed twice with distilled water by centrifugation and broken with a Mickle disintegrator by using an equivalent weight of cells and glass beads (0.13 mm in diameter). Approximately 75 to 80% cell breakage was obtained in 10 min by this technique (as estimated by microscopic observation). The walls were recovered as a white layer on the unbroken cell pellet after centrifugation at 32,000 X g for 20 min. The resulting walls were washed twice with cold, distilled water and purified by incubation overnight at 37 C in 0.025 M tris(hydroxymethyl)aminomethane (Tris)-hydrochloride buffer (pH 7.5) containing trypsin (100 ,g/ml) and ribonuclease (10,ug/ml). A thin layer of toluene was used to retard contamination of the walls during this incubation. After enzyme treatment, the walls were successively washed with 25-ml volumes of cold, distilled water until the A280 of the wash supernatant fraction was less than 0.05.
The purity of these preparations was ascertained by paper chromatography after acid hydrolysis (6 N HCI, 100 C, 18 hr). After removing the HCl by repeatedly drying the hydrolysate on a steam table, the amino acids were separated on Whatman no. 1 filter paper by using butanol-acetic acid-water (4:1:1 upper phase) by descending chromatography. Significant amounts of only alanine, lysine, glutamic acid, and glycine were detected with ninhydrin.
Adsorption studies. The adsorption of vancomycin and ristocetin to cell walls was demonstrated by the procedure of Best and Durham (3) . Freshly prepared cell walls were suspended in distilled water to the desired level by using a standard curve relating the A540 to dry weight. Adsorption was attained by incubating 2 mg of cell walls with 750 jug of antibiotic at 25 C in a total liquid volume of 3 ml. Cell walls and bound antibiotic were sedimented by centrifugation (12,000 X g for 10 min), and the amount of antibiotic adsorbed was ascertained by measuring the decrease in absorbance of the supernatant solution at 280 nm and relating this reading to a standard absorbance curve for the antibiotic. All spectrophotometric readings were made by using cuvettes with a 1-cm light path.
Extraction and isolation of UDP-N-acetylmuramyl pentapeptide from S. aureus. Four 1-liter flasks containing tryptose broth (500 ml) were inoculated to an A540 value of 0.10 with S. aureus from a 12-hr tryptose agar slant. Cell growth at 37 C was followed spectrophotometrically at 540 nm. When the absorbance reached 0.6 to 0.7 [0.2 to 0.3 mg (dry weight) per ml], the cells were harvested by continuous-flow centrifugation and washed once with 0.10 M potassium phosphate buffer (pH 7.0). The cells were then resuspended in 500 ml of a medium containing (per liter): K2HPO4, 14 g; KH2PO4, 6 g; (NH4)2SO4, 2 g; glucose, 10 g; DL-alanine, D-glutamic acid, L-lysine, glycine, and penicillin, 200 mg each; and 1 ml of a mineral salts solution containing 5% MgSO4, 0.1% MnSO4, and 1.0% FeCI3. Labeled After incubation at 37 C in the above medium for 2 hr, the cells were collected by centrifugation (12,000 X g for 10 min) and extracted by continuously stirring at 4 C with 50 ml of trichloroacetic acid (10%, w/v). After 1 hr, the suspension was centrifuged, and the yellow supernatant solution was recovered. The cells were again suspended in 50 ml of 10% trichloroacetic acid and extracted as before. The combined supernatant solutions were then extracted 4 to 5 times with equal volumes of cold, anhydrous ether to remove the trichloroacetic acid. The resulting pale yellow liquid was taken to near dryness by rotary evaporation at 30 C and was then dissolved in 1 to 2 ml of distilled water.
The extracted nucleotides were applied to a Sephadex G-25 column (50 by 3 cm) and eluted with distilled water. Fractions (5 ml) were assayed spectrophotometrically at 260 nm and 0.1-ml portions were hydrolyzed with 0.1 N HCI (100 C for 100 min), neutralized with NaOH, and analyzed for N-acetylamino sugar content by the method of Reissig et al. (11) . A single, broad peak of N-acetylamino sugar was pooled and taken to near dryness by rotary evaporation at 30 C. This material was applied to another Sephadex G-25 column (60 by 1.5 cm), rinsed onto the bed with 2.0 ml of distilled water, and eluted with distilled water. Fractions (5 ml) were again collected and assayed as before. The first and largest peak containing N-acetylamino sugar was pooled and freezedried. The identity of this nucleotide peptide was shown to be UDP-N-acetylmuramyl-L-alanyl-Disoglutaminyl-L-lysyl-D-alanyl-D-alanine (UDP-MurNAc-pentapeptide) by automatic amino acid analysis, N-acetyl-amino sugar analysis (11), phosphate analysis (5) , and by ultraviolet absorption ratios (9) . Radioactivity measurements. All radioactivity measurements were made using a Packard Tri-Carb liquid scintillation spectrometer. Samples (0.1 ml) were mixed with 10 ml of scintillation fluid composed of 1,4-bis-[2-(4-methyl-5-phenyl-oxazyl)] benzene, 0.2 g; diphenyloxazole, 4.0 g; absolute ethanol, 400 ml; and toluene, 600 ml.
Differential absorption measurements. The complex between vancomycin or ristocetin and UDP-MurNAc-pentapeptide was detected by the procedure of Perkins (10) . One cuvette containing 2.5 ml of the antibiotic and another containing 2.5 ml of distilled water was placed into the reference beam. Identical cuvettes were placed in the sample beam. UDPMurNAc-pentapeptide (0.5 ml) was added to the cuvette containing water in the reference beam and to the cuvette containing antibiotic in the sample beam. The final concentration of antibiotic and nucleotide peptide was 0.16 mm in the respective cuvettes. Water (0.5 ml) was added to the cuvette in the reference beam which contained only antibiotic to correct for dilution. Differential spectra were obtained by scanning absorbance in the range of 320 to 250 nm by using a Cary model 14 recording spectrophotometer.
Calculations of antibiotic concentrations in these experiments assumed a molecular weight of 4,000 for ristocetin and 1,600 for vancomycin, since these were the values used by Perkins (10) . However, the true molecular weight of vancomycin is probably 3,200 (6). Growth studies. The effect of nucleotide pentapeptide on growth inhibition by vancomycin and ristocetin was determined with B. subtilis W-23 growing in a glucose salts medium (2) . Cells from a 12-hr glucose salts slant were grown to an A540 value of 0.5 to 0.6 [0.4 to 0.5 mg (dry weight) per ml] at 37 C in the liquid glucose salts medium. Five milliliters of these actively growing cells was then used to inoculated 125-ml flasks containing glucose salts medium (20 ml), antibiotic, nucleotide peptide as indicated, and distilled water to give a final liquid volume of 25 ml. The antibiotic concentration was adjusted to that level which gave complete inhibition of growth without lysis of the cells. An initial A540 value of 0.15 [0.1 mg (dry weight) per ml] was obtained in each flask, and growth was followed turbidimetrically at 540 nm at 30-min intervals. All flasks were shaken in a water bath at 37 C during growth measurements.
RESULTS
Adsorption of vancomycin and ristocetin to Micrococcus Iysodeikticus cell walls. Figure 1 either vancomycin or ristocetin and nucleotide pentapeptide have been confirmed by using differential absorption spectra (10) . As shown in Fig. 2 a 2:1 proportion of antibiotic to UDP-MurNAcpentapeptide resulted in a slight increase (about 10%) in the apparent amount of complex formed. The difference spectra in Fig. 2 were obtained by using 0.16 mm UDP-MurNAc-pentapeptide, 0.32 mm vancomycin (assumed molecular weight of 1,600), and 0.16 mm ristocetin (assumed molecular weight of 4,000).
Effect of UDP-N-acetylmuramyl pentapeptide on ristocetin B and vancomycin adsorption to cell walls. Since both antibiotics and the nucleotide peptide absorb ultraviolet light at 280 nm, the effect of the latter on antibiotic adsorption to cell walls could not be accurately measured by using only the standard spectrophotometric assay of Best and Durham (3). An indication of the relative affinity of the antibiotics for cell walls and for the peptidoglycan precursor was obtained, however, by using this assay in combination with "C-labeled nucleotide pentapeptide. The results presented in Table 1 depict the effect of two levels of nucleotide pentapeptide on the adsorption of a Ristocetin B and 14C-UDP-MurNAc-pentapeptide, at the indicated concentrations, were brought to a final liquid volume of 3.0 ml with distilled water. In those tubes containing cell walls (2 mg), the contents were centrifuged at 10,000 X g for 10 min before absorbance and radioactivity measurements. The antibiotic and nucleotide peptide were mixed together separately before their addition to tubes containing cell walls in samples 5 and 6. vancomycin and ristocetin to M. lysodeikticus cell walls. A comparison of the A2N readings indicated that adsorption of ristocetin in samples 5 and 6 was comparable to that observed in the absence of added nucleotide peptide. These data demonstrate that the ristocetin-nucleotide peptide complex does not bind to walls as a unit, since the radioactivity in samples 5 and 6 was not significantly decreased relative to that in samples 2 and 3. Therefore, ristocetin has a greater affinity for intact cell walls than for the peptidoglycan precursor.
Ristocetin and the labeled nucleotide peptide were mixed before incubation with the cell walls in the experiment described in Table 1 . To directly determine the fate of the antibiotic-nucleotide peptide complex in the presence of cell walls, the two components were mixed in the cuvette as described previously, and complex formation was confirmed by the resulting differential absorption spectrum. This complex was then quantitatively mixed with sedimented cell walls. After 10 min at 25 C, the suspension was centrifuged to remove the cell walls and any bound material. The resulting supernatant solution was recovered quantitatively, and a 0.1-ml amount was removed for radioactivity measurement. The remainder of the supernatant solution was returned to the cuvette to assess the effect of incubation with cell walls on the previous differential absorption spectrum. The excessive absorbance by the reference beam relative to the sample beam assured that adsorption of antibiotic had occurred, and the radioactivity measurements (Table 2) Fig. 2 . The complex was mixed with M. lysodeikticus cell walls (2 mg). After removing the walls by centrifugation, the supematant solution was quantitatively recovered, and the radioactivity was measured.
revealed that all the radioactivity remained in the supernatant solution after adsorption. Identical results were obtained by using either vancomycin or ristocetin B. Thus, both antibiotics have a greater affinity for cell walls than for UDPMurNAc-pentapeptide, and there is no indication that the complex of the latter and antibiotic binds to cell walls.
Effect of complexed antibiotic on growth of Bacillus subtilis. If the mechanism of action of vancomycin and ristocetin depends on the formation of a stable complex with the lipid-bound disaccharide pentapeptide as proposed by Perkins (10) , prior incubation of the antibiotics, with sufficient peptidoglycan precursor to assure maximum complex formation, would be expected to at least reduce the biological activity of the inhibitors. However, if the inhibition of peptidoglycan synthesis depends on the adsorption of an antibiotic molecule at a cell wall site proximal to the site of addition of the disaccharide pentapeptide precursor, the previously demonstrated affinity of these antibiotics for cell walls relative to UDP-MurNAc-pentapeptide should result in essentially complete growth inhibition, in spite of an excess of exogenous nucleotide pentapeptide.
The results presented in Fig. 3 show the effect of UDP-MurNAc-pentapeptide on growth inhibition by vancomycin or ristocetin B. The levels of both antibiotics were carefully selected to give a complete inhibition of growth. Even slightly higher concentrations of either antibiotic resulted in lysis and a 10% reduction in the concentration of either vancomycin or ristocetin allowed some increase in turbidity. As indicated, nucleotide pentapeptide, even at an eightfold excess over that required for maximum complex formation, did not affect the inhibition of growth of B. subtilis by ristocetin B or vancomycin. This result was not altered by premixing the antibiotics with all levels of nucleotide pentapeptide before their addition to the growth medium. DISCUSSION Two mechanisms of action for vancomycin and ristocetin inhibition of peptidoglycan synthesis have been proposed. The first, by Best and Durham (3), was based on the observed adsorption of these antibiotics to whole cells and isolated cell walls. According to their proposal, those molecules of antibiotic which are bound at sites of active wall synthesis should block the addition of the lipid-bound disaccharide pentapeptide to the growing peptidoglycan polymer. Support for the significance of adsorbed antibiotic was provided by Sinha and Neuhaus (14) who observed that isolated cell walls of M. lysodeikticus reversed the inhibition of cell-free peptidoglycan synthesis by vancomycin and ristocetin. These results established that the antibiotics have a greater affinity for walls than for the other components in the cell-free preparations. The latest mechanism of action which has been proposed holds that the complex which is formed between these inhibitors and the pentapeptide precursors having a D-alanyl-D-alanine C-terminus could block synthesis of peptidoglycan by preventing the enzymatic transfer of the disaccharide peptide from the lipid carrier to the growing peptidoglycan chain (10) .
Both of the proposed mechanisms of action would affect the same step in the biosynthetic sequence, and both would affect the same reac-tion defined by Anderson et al. as being most sensitive to these antibiotics, i.e., the transfer of lipid-bound disaccharide pentapeptide to an acceptor which would be the existing peptidoglycan polymer in vivo (1) . The evidence presented in this paper would appear to favor a mechanism of inhibition based on adsorption. First, both vancomycin and ristocetin have a greater affinity for walls than for UDP-MurNAc-pentapeptide. In addition, complexed antibiotic is no less inhibitory than free antibiotic. Finally, the exceptional affinity of vancomycin and ristocetin for isolated cell walls makes it difficult to rationalize the penetration of significant amounts of antibiotic through existing walls to the membranebound peptidoglycan precursor. As pointed out previously, one mg (dry weight) of B. subtilis cell walls can adsorb 750 ,g of vancomycin (3) . Thus, at reasonable levels of inhibitor, adsorption to the external cell wall would certainly precede and likely preclude appreciable penetration of either antibiotic to the membrane.
In choosing between the two mechanisms of action, there is an interesting paradox to consider with regard to adsorption and complex formation chemistry. Both processes appear to involve an interaction between the antibiotics and carboxyl groups. The involvement of these groups was initially demonstrated by esterifying cell walls with diazomethane, a treatment which completely prevented the adsorption of vancomycin (3) . This observation and the fact that divalent cations reduce adsorption and alleviate growth inhibition by vancomycin indicated that ionic linkages were involved in the adsorption phenomenon.
As demonstrated by Perkins (10) , complex formation specifically involves the D-alanyl-Dalanine carboxyl terminus on the peptide. Although the chemical nature of this complex is not known, esterification of the terminal carboxyl group also eliminates complex formation (10) . Magnesium, at 0.01 M, has no effect on the differential spectrum obtained with vancomycin and nucleotide peptide (Best and McConnell, unpublished data). These results suggest that although both adsorption to walls and complex formation involves carboxyl groups, different associations could be involved in the two processes. In addition, the more attractive mechanism of action (adsorption to cell walls) implies a lack of specificity which is disturbingly apparent in the alternative proposal. A large number of innocuous binding events to several possible groups on the cell wall surface must be acknowledged. Only those adsorption events in the vicinity of active cell wall synthesis can be considered effective. This situation is contrasted with the specificity apparent in the complex formed between these antibiotics and peptides containing a D-alanyl-D-alanine C-terminus. As pointed out by Perkins (10) , it is difficult to reconcile the specificity of vancomycin and ristocetin toward these peptides without invoking significance to the resulting complex.
It would be tempting to compromise the two theories and suggest that an interaction between antibiotic and either cell wall or wall precursor could be involved in the eventual inhibition of peptidoglycan synthesis. However, the alleviation of growth inhibition by divalent cations can not be accommodated to the complex formation proposal as yet. Since such cations both alleviate growth inhibition and reduce adsorption to isolated cell walls (2-4, 14) any mechanism of action for vancomycin and ristocetin must account for this fact. If adsorption to cell wall is considered fortuitous and inconsequential, and if divalent cations have no effect on complex formation, then these cations should enhance rather than decrease the activity of these antibiotics. This would be expected since the cations would decrease adsorption of the antibiotics to the wall and more molecules would be available to participate in complex formation.
Although it would be difficult to prove that the adsorption of vancomycin and ristocetin to cell walls is not responsible for the inhibition of peptidoglycan synthesis, additional information on the significance of complex formation with precursor peptides might be obtained with cellfree peptidoglycan-synthesizing systems. If complex formation is responsible for inhibition, a given level of this inhibition might be reversed by increasing the amount of UDP-MurNAc-pentapeptide relative to either antibiotic in the incubation mixture. However, if complexed antibiotic is as inhibitory in the cell-free system as in the growth studies reported here, then support for the adsorption concept would be indicated.
